EUVIMEDEUVIMED entdecken
Crossref

Structure-Guided Designed [18F]-labeled FAPI for Enhanced Hydrophilicity: From Preclinical to First-In-Human Study

Xingyu Mu, Lei Zhang, Zihao Chen, Hoi Yee Chow, Jingze Li, Weixia Chong, Yufeng Mo, Ganghua Tang iD, Xuechen Li iD, Wei Fu iD

Journal of Medicinal Chemistry · 2026

DOI: 10.1021/acs.jmedchem.5c03486 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Xingyu Mu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The First Affiliated Hospital of Guilin Medical University, Guilin 541001, China. Hauptthemen laut MEDLINE: Fibroblast Activation Protein Alpha, Fluorine Radioisotopes, Gelatinases, Radiopharmaceuticals. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Guangxi Zhuang Autonomous Region Health and Family Planning Commission, Morningside Foundation, Natural Science Foundation of Guangxi Zhuang Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibroblast activation protein (FAP) is highly expressed in cancer-associated fibroblasts and represents an attractive target for PET imaging. Here, we report [18F]AlF-NOTA-GL01, an improved FAPI-46 derivative bearing an N-methyl-benzenesulfonic acid side chain and labeled via an Al[18F]-NOTA platform. [18F]AlF-NOTA-GL01 was obtained with high radiochemical purity (>95%), high FAP binding affinity (IC50 = 2.94 nM), and high hydrophilicity (LogD = −3.06). In A549-hFAP xenografts, PET imaging showed high tumor uptake (7.45 ± 2.34%ID/g at 60 min), rapid renal clearance, and low hepatobiliary background, with strong concordance between PET-derived uptake and ex vivo biodistribution. In a first-in-human study, physiologic uptake decreased over time, whereas tumor uptake persisted to 120 min. The effective dose was 0.03 ± 0.01 mSv/MBq. Malignant lesions exhibited higher target-to-background ratios on [18F]AlF-NOTA-GL01 PET/CT than on [18F]FDG and [18F]FAPI-42. Collectively, these findings support the clinical translation potential of [18F]AlF-NOTA-GL01, which combines high affinity with excellent imaging contrast.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibroblast Activation Protein AlphaFluorine RadioisotopesGelatinasesRadiopharmaceuticalsAnimalsFemaleHumansMiceCell Line, TumorDrug DesignHydrophobic and Hydrophilic InteractionsPositron-Emission TomographySerine EndopeptidasesTissue Distribution

Substanzen

Fibroblast Activation Protein AlphaFluorine RadioisotopesFluorine-18GelatinasesRadiopharmaceuticalsSerine Endopeptidases

Autor:innen und Institutionen

  • Department of Nuclear Medicine, The First Affiliated Hospital of Guilin Medical University, Guilin 541001, China.
  • Guilin Translational Science and Technology Innovation Center for Nuclear Medicine and Molecular Imaging, The First Affiliated Hospital of Guilin Medical University, Guilin 541001, China.
  • Key Laboratory Project of Guangdong Provincial Department of Education for Ordinary Universities and GDMPA Key Laboratory for Quality Control and Evaluation of Radiopharmaceuticals, Department of Nuclear Medicine, Nanfa…
  • School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, Guangdong 510515, China.
  • Serilink Biotechnology Company Limited, Hong Kong 999077, China.
  • Department of Chemistry, State Key Laboratory of Synthetic Chemistry, The University of Hong Kong, Hong Kong 999077, China.

ORCID-Profile: Ganghua Tang, Xuechen Li, Wei Fu

Förderung

  • Guangxi Zhuang Autonomous Region Health and Family Planning Commission
  • Morningside Foundation
  • Natural Science Foundation of Guangxi Zhuang Autonomous Region
  • National Natural Science Foundation of China

Zitieren

APA

Mu, X., Zhang, L., Chen, Z., Chow, H. Y., Li, J., Chong, W., Mo, Y., Tang, G., Li, X., & Fu, W. (2026). Structure-Guided Designed [18F]-labeled FAPI for Enhanced Hydrophilicity: From Preclinical to First-In-Human Study. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c03486

Vancouver

Mu X, Zhang L, Chen Z, Chow HY, Li J, Chong W, et al. Structure-Guided Designed [18F]-labeled FAPI for Enhanced Hydrophilicity: From Preclinical to First-In-Human Study. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.5c03486

BibTeX
@article{Mu2026,
  author = {Mu, Xingyu and Zhang, Lei and Chen, Zihao and Chow, Hoi Yee and Li, Jingze and Chong, Weixia and Mo, Yufeng and Tang, Ganghua and Li, Xuechen and Fu, Wei},
  title = {Structure-Guided Designed [18F]-labeled FAPI for Enhanced Hydrophilicity: From Preclinical to First-In-Human Study},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.5c03486}
}
Kostenlos starten →